SonoScape Medical Corp. (SHE:300633)

Market Cap	10.07B -24.5%
Revenue (ttm)	2.36B +20.1%
Net Income	177.60M +253.2%
EPS	0.41 +255.5%
Shares Out	430.32M
PE Ratio	56.53
Forward PE	33.85
Dividend	0.18 (0.75%)
Ex-Dividend Date	May 29, 2025

Volume	317,500
Average Volume	7,208,951
Open	24.12
Previous Close	23.39
Day's Range	23.32 - 24.12
52-Week Range	23.13 - 37.73
Beta	-0.32
RSI	32.25
Earnings Date	Apr 17, 2026

About SonoScape Medical

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery soluti...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 3,133
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300633

Financial Performance

In 2025, SonoScape Medical's revenue was 2.31 billion, an increase of 14.65% compared to the previous year's 2.01 billion. Earnings were 197.28 million, an increase of 38.54%.